目的 研究不同剂量茵栀黄口服液与不同浓度金银花提取物对葡萄糖-6-磷酸脱氢酶(G6PD)缺乏大鼠的溶血影响和退黄疗效比较。方法 将实验用雄性Wistar大鼠随机分为10组,每组10只,分别为正常组(不予任何处理)、阴性对照组(给予生理盐水)、阳性对照组(给予伯氨喹啉)、2倍剂量茵栀黄组(给予13.4 mL/kg茵栀黄口服液)、4倍剂量茵栀黄组(给予26.8 mL/kg茵栀黄口服液)、8倍剂量茵栀黄组(给予53.6 mL/kg茵栀黄口服液)、正常浓度金银花组(给予剂量为6.7 mL/kg,浓度为8 mg/mL金银花提取物)、中浓度金银花组(给予剂量为6.7 mL/kg,浓度为40 mg/mL金银花提取物)、高浓度金银花组(给予剂量为6.7 mL/kg,浓度为80 mg/mL金银花提取物)、极高浓度金银花组(给予剂量为6.7 mL/kg,浓度为160 mg/mL金银花提取物)。除正常组外,其余各组通过乙酰苯肼制造G6PD缺乏大鼠模型,通过瑞氏染色观察造模前后大鼠红细胞形态变化;造模后各组给予相应药物进行处理,用血常规及血生化检测仪检测相关溶血指标,以及血总胆红素和间接胆红素水平。结果 G6PD缺乏大鼠红细胞形态不规则,中央区染色变浅。与造模前相比,阳性对照组给药后红细胞计数下降,游离血红蛋白水平和网织红细胞百分比均上升(P < 0.05);不同剂量茵栀黄组和不同浓度金银花组只有网织红细胞百分比均高于造模前水平(P < 0.05)。不同剂量茵栀黄组总胆红素和间接胆红素水平均较阳性对照组下降(P < 0.05),不同浓度金银花组间接胆红素水平低于阳性对照组(P < 0.05),但总胆红素水平高于各剂量茵栀黄组(P < 0.05)。与4倍剂量和8倍剂量茵栀黄组相比,2倍剂量茵栀黄组给药后大鼠总胆红素水平下降百分比最高(P < 0.05)。结论 大剂量茵栀黄口服液与不同浓度金银花提取物均不会引起G6PD缺乏大鼠发生溶血;茵栀黄口服液退黄疗效比金银花提取物好,且其疗效可能并不随剂量增大而提高。
Abstract
Objective To investigate the effects of different doses of Yinzhihuang oral liquid and different concentrations of Lonicera japonica extract on hemolysis and hyperbilirubinemia in rats with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Methods Male Wistar rats were randomly divided into 10 groups (n=10 each):normal control group (untreated), negative control group (saline-treated), positive control group (primaquine-treated), low-, medium-and high-dose Yinzhihuang oral liquid groups (13.4, 26.8, and 53.6 mL/kg, respectively), and low-, medium-, high-, and very-high-concentration Lonicera japonica groups (6.7 mL/kg administered, containing 8, 40, 80, and 160 mg/mL Lonicera japonica extract, respectively). A rat model of acetylphenylhydrazine-induced G6PD deficiency was established in all groups except the normal control group, as confirmed by the morphological changes in erythrocytes observed using Wright's stain. After treatment, routine blood and biochemical tests were conducted to measure hemolytic indices, as well as changes in total and indirect bilirubin levels. Results Rats with G6PD deficiency demonstrated irregular erythrocytes with a lighter-staining center. In the positive control group, the red blood cell count decreased, while the free hemoglobin count and the reticulocyte percentage increased, as compared with before treatment (P < 0.05); in all the Yinzhihuang oral liquid groups and Lonicera japonica extract groups, all the above indices except reticulocyte percentage returned to the levels before treatment (P < 0.05). Compared with the positive control group, all the Yinzhihuang oral liquid groups had significantly reduced total and indirect bilirubin levels (P < 0.05), and all the Lonicera japonica group had significantly reduced indirect bilirubin levels (P < 0.05). However, the total bilirubin level was significantly higher in the Lonicera japonica groups than in the Yinzhihuang oral liquid groups (P < 0.05). The low-dose Yinzhihuang oral liquid group demonstrated a significantly greater decrease in total bilirubin level than the medium-and high-dose Yinzhihuang oral liquid group (P < 0.05). Conclusions Administration of high-dose Yinzhihuang oral liquid and different concentrations of Lonicera Japonica extract do not cause hemolysis in rats with G6PD deficiency. Yinzhihuang oral liquid is more effective in treating hyperbilirubinemia than Lonicera Japonica extract. However, the efficacy of Yinzhihuang oral liquid may not be dose-dependent.
关键词
茵栀黄口服液 /
金银花 /
葡萄糖-6-磷酸脱氢酶 /
溶血 /
大鼠
Key words
Yinzhihuang oral liquid /
Lonicera japonica /
Glucose-6-phosphate dehydrogenase /
Hemolysis /
Rats
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 杜立中. 新生儿高胆红素血症[M]. 北京:人民卫生出版社, 2015:34-45.
[2] 刘备, 马国. 新生儿黄疸的治疗药物研究进展[J]. 中国医院药学杂志, 2015, 35(16):1515-1519.
[3] 黄喜茹, 刘伟娜,曹冬. 金银花的化学成分药理作用研究评析[J].中医药学刊, 2005, 23(3):418-419.
[4] 钱宏梁, 潘志强. 中医血虚证及其动物模型制备方法评析[J]. 广州中医药大学学报, 2018, 35(1):176-181.
[5] 王艳伟, 乔利, 刘春芳, 等. 黄连对乙酰苯肼所致小鼠红细胞氧化性溶血的影响及作用机制[J]. 中国中药杂志, 2010, 35(18):2449-2452.
[6] 魏伟, 吴希美, 李元建. 药理实验方法学[M]. 第4版. 北京:人民卫生出版社, 2017, 7:69-80.
[7] 台雪姣, 郭兴荣, 罗超, 等. 小鼠颌下采血法改良[J]. 四川动物, 2017, 36(2):211-214.
[8] Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency[J]. Hematol Oncol Clin North Am, 2016, 30(2):373-393.
[9] 马印图, 李莉华, 李玉秋, 等. 茵栀黄口服液临床应用研究进展[J]. 解放军医药杂志, 2014, 26(6):88-91.
[10] 范建伟, 李蔚群, 李艳芳, 等. 茵栀黄制剂处方渊源、剂型沿革与质量控制的研究进展[J]. 中成药, 2017, 39(11):2365-2368.
[11] Cuperus FJ, Hafkamp AM, Hulzebos CV, et al. Pharmacological therapies for unconjugated hyperbilirubinemia[J]. Curr Pharm Des, 2009, 15(25):2927-2938.
[12] Fok TF. Neonatal jaundice-traditional Chinese medicine approach[J]. J Perinatol, 2001, 21 Suppl 1:S98-S100.
[13] Chen SP, Tian LL, Liu FL. Clinical observation of Yinzhihuang Oral Liquid on prevention of the premature infantile jaundice[J]. Chin J Integr Med, 2009, 15(4):299-302.(中文杂志请改中文)
[14] 陈锦文, 唐丽君, 黄为民. 茵栀黄口服液对G6PD酶活性下降大鼠溶血及红细胞膜ATP酶活性的影响[J]. 世界中西医结合杂志, 2015, 10(6):774-778.
[15] 茵栀黄口服液临床研究协作组. 茵栀黄口服液治疗足月新生儿高间接胆红素血症的多中心随机对照研究[J]. 中华儿科杂志, 2011, 49(9):663-668.
[16] 杨倩茹, 赵媛媛, 郝江波, 等. 金银花与山银花化学成分及其差异的研究进展[J]. 中国中药杂志, 2016, 41(7):1204-1211.
[17] Vo NNQ, Fukushima EO, Muranaka T. Structure and hemolytic activity relationships of triterpenoid saponins and sapogenins[J]. J Nat Med, 2017, 71(1):50-58.
[18] Thanabhorn S, Jaijoy K, Thamaree S, et al. Acute and subacute toxicity study of the ethanol extract from Lonicera japonica Thunb[J]. J Ethnopharmacol, 2006, 107(3):370-373.